Profile
International Journal of Clinical Research & Trials Volume 2 (2017), Article ID 2:IJCRT, 2 pages
https://doi.org/10.15344/2456-8007/2017/114
Letters to the Editor
Shifting Profile of MDR-TB Patients in Northern Portugal?

Olena Oliveira1*, A. Rita Gaio2,3, Anabela Silva4,5, Rita Macedo4 and Raquel Duarte1,4,6,7

1EPIUnit, Institute of Public Health, University of Porto, Portugal
2Mathematics Department, Faculty of Sciences of the University of Porto, Porto, Portugal
3Centre of Mathematics of the University of Porto, Porto, Portugal
4Reference Centre for Multidrug-resistant tuberculosis in the North Region of Portugal, Chest Disease Centre of Vila Nova de Gaia, Portugal
5National Health Institute Doutor Ricardo Jorge, Portugal
6Pulmonology Department, Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE, Vila Nova de Gaia, Portugal
7Department of Clinical Epidemiology, Predictive Medicine and Public Health, Universityof Porto, Porto, Portugal
Dr. Olena Oliveira, EPIUnit, Institute of Public Health, University of Porto, Portugal; E-mail: abernardo@egasmoniz.edu.pt
05 April 2017; 28 June 2017; 30 June 2017
Oliveira O, Gaio AR, Silva A, Macedo R, Duarte R (2017) Shifting Profile of MDR-TB Patients in Northern Portugal?. Int J Clin Res Trials 2: 114. doi: https://doi.org/10.15344/2456-8007/2017/114

References

  1. World Health Organization. Reaching people with MDR-TB. Progressing in diagnosis: a key step in overcoming the MDR-TB crisis. Geneve, WHO, 2014
  2. World Health Organization. Best practices in prevention, control and care for drug- resistant tuberculosis. Copenhagen, WHO Regional Office for Europe, 2013
  3. World Health Organization. Global tuberculosis report 2015. WHO/HTM/ TB/2015.22 Geneva, WHO, 2014
  4. European Centre for Disease Prevention and Control (2016) Annual Epidemiological Report, 2016 – Tuberculosis. Stockholm: ECDC
  5. European Centre for Disease Prevention and Control. ECDC special report. Progressing towards TB elimination. A follow-up to the Framework Action Plan to Fight Tuberculosis in the European Union. Stockholm: ECDC; 2016
  6. Direção – Geral da Saúde. Portugal, Infeção VIH/SIDA e Tuberculose emnúmeros-2015. Programa Nacional para a Infeção VIH/SIDA
  7. Direção -Geral da Saúde. SVIG-TB
  8. Gomes C. CRTMR Programa Nacional de Luta Contra a Tuberculose. As recomendações para a gestão da TBMR. DGS/PNT/CRTMR/2008.001. Lisboa, DGS, 2008
  9. Direcção – Geral da Saúde. Centro de Referência para Tuberculose Multirresistente (CRTMR). Circular Informativa nº 14/DT de 05/06/07. Lisboa: DGS, 2007
  10. Administração Regional de Saúde do Norte. Centro de Referencia Regional para a TBMR. ARS Norte, 23 de Abril 2009
  11. Duarte R, Santos A, Mota M, Carvalho A, Marques A, et al. (2011) Involving community partners in the management of tuberculosis among drug users. Public Health 125: 60-62 [CrossRef] [Google Scholar] [PubMed]
  12. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency update, 2008. WHO/HTM/TB/2008.402. Geneva, WHO, 2008 [Google Scholar]
  13. World Health Organization. The global plan to stop TB 2011-2015: transforming the fight towards elimination of tuberculosis. WHO/HTM/STB/2010.2. Geneva, WHO 2010 [Google Scholar]